Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
- PMID:23020937
- DOI: 10.1016/S0140-6736(12)61480-9
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
Abstract
Background: The genetic cause of intellectual disability in most patients is unclear because of the absence of morphological clues, information about the position of such genes, and suitable screening methods. Our aim was to identify de-novo variants in individuals with sporadic non-syndromic intellectual disability.
Methods: In this study, we enrolled children with intellectual disability and their parents from ten centres in Germany and Switzerland. We compared exome sequences between patients and their parents to identify de-novo variants. 20 children and their parents from the KORA Augsburg Diabetes Family Study were investigated as controls.
Findings: We enrolled 51 participants from the German Mental Retardation Network. 45 (88%) participants in the case group and 14 (70%) in the control group had de-novo variants. We identified 87 de-novo variants in the case group, with an exomic mutation rate of 1·71 per individual per generation. In the control group we identified 24 de-novo variants, which is 1·2 events per individual per generation. More participants in the case group had loss-of-function variants than in the control group (20/51 vs 2/20; p=0·022), suggesting their contribution to disease development. 16 patients carried de-novo variants in known intellectual disability genes with three recurrently mutated genes (STXBP1, SYNGAP1, and SCN2A). We deemed at least six loss-of-function mutations in six novel genes to be disease causing. We also identified several missense alterations with potential pathogenicity.
Interpretation: After exclusion of copy-number variants, de-novo point mutations and small indels are associated with severe, sporadic non-syndromic intellectual disability, accounting for 45-55% of patients with high locus heterogeneity. Autosomal recessive inheritance seems to contribute little in the outbred population investigated. The large number of de-novo variants in known intellectual disability genes is only partially attributable to known non-specific phenotypes. Several patients did not meet the expected syndromic manifestation, suggesting a strong bias in present clinical syndrome descriptions.
Funding: German Ministry of Education and Research, European Commission 7th Framework Program, and Swiss National Science Foundation.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Comment in
- New mutations and sporadic intellectual disability.Gecz J, Haan E.Gecz J, et al.Lancet. 2012 Nov 10;380(9854):1630-1. doi: 10.1016/S0140-6736(12)61603-1. Epub 2012 Sep 27.Lancet. 2012.PMID:23020936No abstract available.
- Autism and intellectual disability.Tallantyre E, Robertson NP.Tallantyre E, et al.J Neurol. 2013 Mar;260(3):936-9. doi: 10.1007/s00415-013-6861-y.J Neurol. 2013.PMID:23423245No abstract available.
Similar articles
- Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.Baasch AL, Hüning I, Gilissen C, Klepper J, Veltman JA, Gillessen-Kaesbach G, Hoischen A, Lohmann K.Baasch AL, et al.Epilepsia. 2014 Apr;55(4):e25-9. doi: 10.1111/epi.12554. Epub 2014 Mar 1.Epilepsia. 2014.PMID:24579881Review.
- High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.Martínez F, Caro-Llopis A, Roselló M, Oltra S, Mayo S, Monfort S, Orellana C.Martínez F, et al.J Med Genet. 2017 Feb;54(2):87-92. doi: 10.1136/jmedgenet-2016-103964. Epub 2016 Sep 12.J Med Genet. 2017.PMID:27620904
- Exome sequencing identifies three novel candidate genes implicated in intellectual disability.Agha Z, Iqbal Z, Azam M, Ayub H, Vissers LE, Gilissen C, Ali SH, Riaz M, Veltman JA, Pfundt R, van Bokhoven H, Qamar R.Agha Z, et al.PLoS One. 2014 Nov 18;9(11):e112687. doi: 10.1371/journal.pone.0112687. eCollection 2014.PLoS One. 2014.PMID:25405613Free PMC article.
- Diagnostic exome sequencing in persons with severe intellectual disability.de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE.de Ligt J, et al.N Engl J Med. 2012 Nov 15;367(20):1921-9. doi: 10.1056/NEJMoa1206524. Epub 2012 Oct 3.N Engl J Med. 2012.PMID:23033978
- A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, Mort M, Cooper DN.Ku CS, et al.Mol Psychiatry. 2013 Feb;18(2):141-53. doi: 10.1038/mp.2012.58. Epub 2012 May 29.Mol Psychiatry. 2013.PMID:22641181Review.
Cited by
- Atomistic simulations reveal impacts of missense mutations on the structure and function of SynGAP1.Ali AE, Li LL, Courtney MJ, Pentikäinen OT, Postila PA.Ali AE, et al.Brief Bioinform. 2024 Sep 23;25(6):bbae458. doi: 10.1093/bib/bbae458.Brief Bioinform. 2024.PMID:39311700Free PMC article.
- Proteomic and genomic characterization of a yeast model for Ogden syndrome.Dörfel MJ, Fang H, Crain J, Klingener M, Weiser J, Lyon GJ.Dörfel MJ, et al.Yeast. 2017 Jan;34(1):19-37. doi: 10.1002/yea.3211. Epub 2016 Dec 6.Yeast. 2017.PMID:27668839Free PMC article.
- SETD5 Gene Haploinsufficiency in Three Patients With Suspected KBG Syndrome.Crippa M, Bestetti I, Maitz S, Weiss K, Spano A, Masciadri M, Smithson S, Larizza L, Low K, Cohen L, Finelli P.Crippa M, et al.Front Neurol. 2020 Jul 24;11:631. doi: 10.3389/fneur.2020.00631. eCollection 2020.Front Neurol. 2020.PMID:32793091Free PMC article.
- Exome Sequencing and the Management of Neurometabolic Disorders.Tarailo-Graovac M, Shyr C, Ross CJ, Horvath GA, Salvarinova R, Ye XC, Zhang LH, Bhavsar AP, Lee JJ, Drögemöller BI, Abdelsayed M, Alfadhel M, Armstrong L, Baumgartner MR, Burda P, Connolly MB, Cameron J, Demos M, Dewan T, Dionne J, Evans AM, Friedman JM, Garber I, Lewis S, Ling J, Mandal R, Mattman A, McKinnon M, Michoulas A, Metzger D, Ogunbayo OA, Rakic B, Rozmus J, Ruben P, Sayson B, Santra S, Schultz KR, Selby K, Shekel P, Sirrs S, Skrypnyk C, Superti-Furga A, Turvey SE, Van Allen MI, Wishart D, Wu J, Wu J, Zafeiriou D, Kluijtmans L, Wevers RA, Eydoux P, Lehman AM, Vallance H, Stockler-Ipsiroglu S, Sinclair G, Wasserman WW, van Karnebeek CD.Tarailo-Graovac M, et al.N Engl J Med. 2016 Jun 9;374(23):2246-55. doi: 10.1056/NEJMoa1515792. Epub 2016 May 25.N Engl J Med. 2016.PMID:27276562Free PMC article.
- Evaluation of autosomal dominant retinal dystrophy genes in an unaffected cohort suggests rare or private missense variants may often be benign.Strom SP, Gorin MB.Strom SP, et al.Mol Vis. 2013 May 6;19:980-5. Print 2013.Mol Vis. 2013.PMID:23687434Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases